Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$686M |
| 2 |
Merck
MRK
|
+$536M |
| 3 |
GoDaddy
GDDY
|
+$330M |
| 4 |
CSX Corp
CSX
|
+$227M |
| 5 |
Aramark
ARMK
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$372M |
| 2 |
DexCom
DXCM
|
+$339M |
| 3 |
Broadcom
AVGO
|
+$321M |
| 4 |
Adobe
ADBE
|
+$280M |
| 5 |
Meta Platforms (Facebook)
META
|
+$273M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.38% |
| 2 | Healthcare | 16.14% |
| 3 | Financials | 13.58% |
| 4 | Industrials | 12.86% |
| 5 | Consumer Discretionary | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Bank OZK
OZK
$5.5B
| $39.1M | 0.02% |
1,028,886
-3,835
| -0.4% | -$157K |
|
|
B
652
DELISTED
Barnes Group Inc.
B
| $39M | 0.02% |
548,788
-5,014
| -0.9% | -$332K |
|
653
Rollins
ROL
$18.8B
| $38.7M | 0.02% |
1,434,105
-248,042
| -15% | -$6.4M |
|
654
Lowe's Companies
LOW
$119B
| $37.6M | 0.02% |
327,502
-10,267
| -3% | -$1.07M |
|
655
EXL Service
EXLS
$4.36B
| $37.6M | 0.02% |
2,838,005
-25,535
| -0.9% | -$316K |
|
656
NOV
NOV
$7.35B
| $37.5M | 0.02% |
870,332
+728,120
| +512% | +$32.6M |
|
657
argenx
ARGX
$55.6B
| $37.4M | 0.02% |
493,649
+53,070
| +12% | +$4.71M |
|
658
BancFirst
BANF
$3.89B
| $37.4M | 0.02% |
624,292
-28,145
| -4% | -$1.76M |
|
|
SAGE
659
DELISTED
Sage Therapeutics
SAGE
| $37.4M | 0.02% |
264,663
+87,427
| +49% | +$13.5M |
|
|
COHR
660
DELISTED
Coherent Inc
COHR
| $37.4M | 0.02% |
217,147
-6,333
| -3% | -$1.11M |
|
|
BKI
661
DELISTED
Black Knight, Inc. Common Stock
BKI
| $37.3M | 0.02% |
718,320
+1,878
| +0.3% | +$101K |
|
662
Live Nation Entertainment
LYV
$41.7B
| $37.2M | 0.02% |
682,667
-121,010
| -15% | -$6.13M |
|
663
Mettler-Toledo International
MTD
$27B
| $37.1M | 0.02% |
60,974
-128,028
| -68% | -$75.3M |
|
664
Gen Digital
GEN
$16.1B
| $37.1M | 0.02% |
1,743,569
-931,305
| -35% | -$19M |
|
665
Encompass Health
EHC
$11.3B
| $37.1M | 0.02% |
597,740
+98,711
| +20% | +$6M |
|
|
GAP
666
The Gap Inc
GAP
$7.07B
| $37.1M | 0.02% |
1,284,869
+41,515
| +3% | +$1.24M |
|
667
Adeia
ADEA
$2.88B
| $36.8M | 0.02% |
9,368,394
-3,071,382
| -25% | -$13.1M |
|
668
Ambarella
AMBA
$2.99B
| $36.7M | 0.02% |
948,168
| – | – |
|
669
Prestige Consumer Healthcare
PBH
$2.39B
| $36.3M | 0.02% |
959,215
+16,173
| +2% | +$612K |
|
|
BNCL
670
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $36.3M | 0.02% |
2,148,851
-796
| -0% | -$13.6K |
|
671
Cal-Maine
CALM
$4.2B
| $35.8M | 0.02% |
742,073
-448,770
| -38% | -$21.5M |
|
672
The Mosaic Company
MOS
$7.1B
| $35.7M | 0.02% |
1,098,558
+666,883
| +154% | +$20.1M |
|
|
CTRA
673
DELISTED
Coterra Energy
CTRA
| $35.6M | 0.02% |
1,581,014
-124,608
| -7% | -$2.91M |
|
674
Allegiant Air
ALGT
$2.66B
| $35.4M | 0.02% |
279,230
-8,824
| -3% | -$1.17M |
|
|
JAG
675
DELISTED
Jagged Peak Energy Inc.
JAG
| $35M | 0.02% |
2,527,858
| – | – |
|
Similar funds
Janus Henderson Group's Q3 2018 Portfolio in Review
As of Q3 2018, Janus Henderson Group held 1,505 positions worth $187B, up 6.7% from $175B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Janus Henderson Group's Q3 2018 filing shows 118 new, 660 increased, 620 reduced and 63 closed positions. Its largest new stake was Elanco Animal Health: 1,976,916 shares worth $69M. The largest sale was Biogen, an estimated $372M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2018 buy was Elanco Animal Health: 1,976,916 shares worth $69M.
- Janus Henderson Group added most to Apple in Q3 2018, an estimated $686M increase.
- Janus Henderson Group's biggest Q3 2018 reduction was Biogen, cutting an estimated $372M.
- Janus Henderson Group fully exited Financial Engines, Inc. in Q3 2018, selling an estimated $190M.
- Janus Henderson Group's ten largest holdings make up 16% of its $187B portfolio in Q3 2018.
- Janus Henderson Group opened 118 new positions and closed 63 in Q3 2018.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $187B.
Based on Janus Henderson Group's 13F filing for Q3 2018, filed 9 Nov 2018.